UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors
  • Apr

    17

    UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through regenerative science

    Apr

    15

    UCB presents new data demonstrating quality-of-life impacts for epilepsy patients and caregivers at AAN 2026 meeting

    Apr

    13

    UCB announces new clinical data from its generalized myasthenia gravis (gMG) portfolio at the 2026 American Academy of Neurology (AAN) meeting

    Apr

    01

    UCB’s Catherine Rives and Alexandria Harrold Recognized by Healthcare Businesswomen’s Association (HBA) as Luminary and Rising Star